Atea Pharmaceuticals Cash Flow Statement (2019-2026) | AVIR

Cash Flow Statement Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
1.54M-28.19M117.13M-42.08M-31.34M-8.07M-34.43M-35.47M-28.18M-33.14M-39.16M-63.17M-40.52M-31.15M-33.54M-34.27M-37.16M-42.05M-44.87M-45.44M
Share-based Compensation (Quarter)
10.01M10.99M11.35M11.66M11.91M11.50M11.64M12.54M12.35M12.38M12.16M12.59M12.72M12.16M14.30M6.95M4.67M4.52M4.58M3.73M
Gains from Sales and Divestitures (Quarter)
Gains from Investment Securities (Quarter)
3.23M0.16M10.52M0.72M0.72M0.18M0.28M0.38M0.39M17.02M1.06M1.06M20.17M1.06M22.71M1.05M0.69M0.62M
Non-cash Items (Quarter)
31.24M10.94M0.01M0.01M4.91M5.08M8.56M5.96M6.09M6.09M4.88M8.66M4.58M8.44M26.59M
Cash from Operations (Quarter)
-17.35M22.60M-75.42M-59.01M-19.19M-21.24M-21.55M-29.85M-16.12M-17.59M-21.83M-39.87M-42.20M-23.04M-30.40M-30.56M-32.87M-40.38M-28.22M-46.39M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
7.93M3.09M3.70M4.32M4.34M3.49M3.02M2.60M2.71M1.74M1.32M1.07M0.81M0.58M
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.01M0.01M0.04M0.11M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M0.10M
Change in Working Capital
Change in Account Payables (Quarter)
12.72M11.49M-17.66M-0.88M10.23M-12.77M1.43M-1.85M3.26M-3.57M3.86M16.89M-15.67M0.32M-1.33M2.93M1.46M-5.33M9.43M-3.50M
Change in Accured Expenses (Quarter)
16.96M9.69M10.60M-28.01M-13.57M2.48M1.49M-4.16M0.65M6.41M9.76M-7.82M1.11M-1.60M-5.12M0.35M-2.95M5.52M9.73M-2.71M
Investing Activities
Capital Expenditures (Quarter)
0.70M1.22M0.02M
Change in Acquisitions & Divestments (Quarter)
91.89M181.11M199.78M146.78M75.00M224.00M131.95M106.23M55.10M208.25M116.02M56.08M90.38M104.28M
Cash from Investing Activities (Quarter)
-0.04M-1.88M-486.98M33.49M24.48M46.56M-58.51M27.77M56.80M124.69M-122.01M-3.37M85.61M15.29M41.30M46.59M29.74M
Financing Activities
Other financing activities (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
0.06M0.80M0.14M0.22M-0.08M0.09M0.17M0.09M0.15M0.12M0.14M0.06M0.87M
Shares Repurchased (Quarter)
11.43M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)
0.06M0.80M0.14M0.22M0.15M0.17M0.09M0.15M0.12M-0.35M-14.09M-11.30M0.26M
Change in Cash (Quarter)
-17.29M23.40M-75.28M-58.83M-21.07M-508.07M11.94M-5.21M30.45M-76.01M5.94M17.09M82.48M-144.93M-33.77M54.70M-31.67M-10.38M18.37M-16.40M
Free Cash Flow (Quarter)
-17.35M22.60M-75.42M-59.71M-20.41M-21.26M-21.55M-29.85M-16.12M-17.59M-21.83M-39.87M-42.20M-23.04M-30.40M-30.56M-32.87M-40.38M-28.22M-46.39M
Net Cash Flow (Quarter)
-17.29M23.40M-75.28M-58.83M-21.07M-508.07M11.94M-5.21M30.45M-76.01M5.94M17.09M82.48M-144.93M-33.77M54.70M-31.67M-10.38M18.37M-16.40M